-

Sepragen Corporation Receives ISO 9001:2015 Certification

UNION CITY, Calif.--(BUSINESS WIRE)--Sepragen Corporation, a leader in innovative bioprocessing technologies, is proud to announce that it has achieved ISO 9001:2015 certification, the internationally recognized standard for quality management systems. This milestone demonstrates Sepragen’s unwavering commitment to delivering high-quality products and services that meet the rigorous standards of the bioprocessing industry.

The ISO 9001:2015 certification underscores Sepragen’s dedication to continuous improvement, customer satisfaction, and operational excellence. The certification process involved a comprehensive audit of Sepragen’s quality management system, focusing on processes, risk management, leadership, and the company’s ability to consistently meet customer needs.

“Achieving ISO 9001:2015 certification is a significant milestone for Sepragen Corporation,” said Renu Chabra, Chief Operating Officer. “This accomplishment reflects our team’s hard work and dedication to maintaining the highest standards of quality and reliability in the solutions we provide to our customers. It also reinforces our commitment to advancing bioprocessing innovation while ensuring customer satisfaction and regulatory compliance.”

Sepragen is known for its groundbreaking products, including advanced chromatography systems and bioprocessing solutions that streamline operations and reduce capital and operating costs for biopharmaceutical and biotech companies worldwide. The ISO 9001:2015 certification enhances the company's reputation as a trusted partner and solidifies its position as an industry leader.

With this certification, Sepragen is poised to better serve its global clientele, expand its market presence, and continue developing technologies that empower its customers to achieve their goals efficiently and effectively.

About Sepragen Corporation:

Sepragen Corporation is a leading provider of bioprocessing technologies that enable faster, more efficient, and cost-effective development and manufacturing of biologics. With a strong focus on innovation, quality, and customer service, Sepragen has been serving both the biopharmaceuticals, and nutraceutical industries for well over 3 decades.

For more information about Sepragen Corporation and its ISO 9001:2015 certification, please visit www.sepragen.com.

Contacts

Media contact:
Susan Rathbun at srathbun@sepragen.com

Sepragen Corporation


Release Versions

Contacts

Media contact:
Susan Rathbun at srathbun@sepragen.com

More News From Sepragen Corporation

Shimadzu Invests in Sepragen Corporation

UNION CITY, Calif.--(BUSINESS WIRE)--Sepragen Corporation announced that it has entered into a strategic partnership agreement with Shimadzu Corporation of Japan. Sepragen Corporation, with headquarters in Union City, California, is a leading company specializing in the manufacturing and sales of innovative bioprocess chromatography equipment. Starting in November of this year, Shimadzu will exclusively market and service Sepragen’s products in Japan, South Korea, and Southeast Asia, marking it...
Back to Newsroom